Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2019-07-02 Regulatory Filings
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Reply to Clarification Sought
Regulatory Filings Classification · 90% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. It fits best as a Regulatory Filing (RNS) by default, as a fallback category for miscellaneous or empty filings.
2019-07-02 English
Trading Window
Regulatory Filings Classification · 90% confidence The document text is extremely short (115 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report title, regulatory references, or any indication of the document type. Given the lack of content, it cannot be classified as a report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2019-07-01 English
Cessation
Board/Management Information Classification · 100% confidence The document is a short notice dated June 24, 2019, addressed to the National Stock Exchange of India, announcing the resignation of Mr. Saumil Bharatbhai Chokshi as a Director of the company. It is a formal announcement of a change in the company's board of directors. The document length is only 864 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Board/Management Information (MANG).
2019-06-24 English
Related Party Transactions
Regulatory Filings Classification · 100% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any other information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category Regulatory Filings (RNS).
2019-06-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice from Arvee Laboratories (India) Limited to the National Stock Exchange of India about an upcoming Board Meeting scheduled for May 27, 2019. The agenda includes consideration and approval of the Audited Financial Results for the year ended March 31, 2019, and half-yearly results for the same period, as well as the Auditor's Report and Directors Report. The document is a notice of a meeting to discuss and approve financial results and related reports, not the reports themselves. The document length is short (2038 characters) and it serves as an announcement of the meeting and agenda rather than containing the actual financial statements or detailed reports. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and notice rather than an Annual Report (10-K) or Audit Report (AR).
2019-05-18 English
Disc. under Reg.30 of SEBI (SAST) Reg.2011
Major Shareholding Notification Classification · 95% confidence The document is a disclosure submitted to the National Stock Exchange of India Limited under Regulation 30(3) in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. It details promoter shareholding and persons acting in concert as of March 31, 2019. The content includes specific shareholding percentages and names of promoters, indicating it is a regulatory disclosure about shareholding changes or confirmations. This type of document is a Major Shareholding Notification (MRQ) as it reports on substantial acquisition or holding of shares by promoters and related parties, consistent with SEBI regulations. The document is not an annual report, earnings release, or other financial report but a regulatory filing about shareholding. Therefore, the correct classification is MRQ with high confidence.
2019-04-09 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.